Janardan Khandekar to Drug Evaluation
This is a "connection" page, showing publications Janardan Khandekar has written about Drug Evaluation.
Connection Strength
0.070
-
Phase II study of cisplatin for metastatic prostatic carcinoma. An Eastern Cooperative Oncology Group study. Am J Clin Oncol. 1983 Apr; 6(2):203-5.
Score: 0.013
-
Phase II evaluation of VM-26 in patients with metastatic transitional cell carcinoma of the urinary tract: an Eastern Cooperative Oncology Group study. Cancer Treat Rep. 1982 Feb; 66(2):405-6.
Score: 0.012
-
A phase II study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tract. Cancer. 1989 Dec 15; 64(12):2445-7.
Score: 0.005
-
Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine. Invest New Drugs. 1989 Jul; 7(2-3):255-60.
Score: 0.005
-
Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial. Cancer Treat Rep. 1987 Jun; 71(6):649-50.
Score: 0.004
-
Phase II diaziquone-based chemotherapy trials in patients with anaplastic supratentorial astrocytic neoplasms. J Clin Oncol. 1987 Mar; 5(3):464-71.
Score: 0.004
-
Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma. Neurosurgery. 1986 Mar; 18(3):335-40.
Score: 0.004
-
Phase II trial of teniposide in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial. Cancer Treat Rep. 1986 Feb; 70(2):307-8.
Score: 0.004
-
Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A Phase II study by the Illinois Cancer Council. Cancer. 1985 Sep 15; 56(6):1311-5.
Score: 0.004
-
A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer. Cancer. 1985 Aug 01; 56(3):457-60.
Score: 0.004
-
Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study. Cancer Treat Rep. 1984 Dec; 68(12):1511-2.
Score: 0.004
-
Phase II study of spirogermanium in advanced breast cancer. Cancer Treat Rep. 1984 Dec; 68(12):1515-6.
Score: 0.004
-
Phase II trial of mitolactol in previously treated and untreated patients with advanced colorectal cancer: an Illinois Cancer Council trial. Cancer Treat Rep. 1984 Oct; 68(10):1303-4.
Score: 0.004